Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001023024-07-000021
Filing Date
2007-11-13
Accepted
2007-11-13 16:16:30
Documents
5
Period of Report
2007-09-30

Document Format Files

Seq Description Document Type Size
1 BIOSANTE Q3 2007 10-Q biosante2007q3.htm 10-Q 594378
2 CEO SECTION 302 exhibit31w1.htm EX-31.1 9365
3 CFO SECTION 302 exhibit31w2.htm EX-31.2 10354
4 CEO SECTION 906 exhibit32w1.htm EX-32.1 4146
5 CFO SECTION 906 exhibit32w2.htm EX-32.2 4560
  Complete submission text file 0001023024-07-000021.txt   624333
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 071238427
SIC: 2836 Biological Products, (No Diagnostic Substances)